Browsing: Novo Nordisk
When GLP-1 drugs for diabetes and weight loss, exploded onto the scene two years ago, patients scrambled to get their…
Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a…
Novo Nordisk A/S plans to invest $4.1 billion in another US factory, plowing more money into its biggest market amid…
A whopping 1 in 8 U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and related…
Topline Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Augmedix, the only publicly-traded…
In describing the financial burden caused by the high price of insulin products, a Fortune article summarized the problem: “In…
Even with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them. Mondelez International Inc.,…
Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked…
Topline Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP-1 medications, were not found to cause…